Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

247.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 247.06
Bid (Size) 199.50 (1)
Ask (Size) 269.00 (2)
Prev. Close 247.06
Today's Range 247.06 - 247.06
52wk Range 211.43 - 387.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
From Bio-Rad Laboratories, Inc.
Via Business Wire
5 Analysts Have This To Say About Bio-Rad Laboratories
Via Benzinga

Performance

YTD
-24.3%
-24.3%
1 Month
+9.5%
+9.5%
3 Month
+7.7%
+7.7%
6 Month
-28.1%
-28.1%
1 Year
-10.1%
-10.1%

More News

Read More
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Earnings Scheduled For May 1, 2025
Via Benzinga
A Preview Of Bio-Rad Laboratories's Earnings
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Bio-Rad Reports First-Quarter 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts
Via Benzinga
Expert Ratings For Bio-Rad Laboratories
Via Benzinga
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
From Biodesix, Inc.
Via GlobeNewswire
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
Via Benzinga
Topics Stocks
Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
From Geneoscopy, Inc.
Via Business Wire
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Third-Quarter 2024 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
From Bio-Rad Laboratories, Inc.
Via Business Wire

Frequently Asked Questions

Is Bio-Rad Laboratories, Inc. Class A Common Stock publicly traded?
Yes, Bio-Rad Laboratories, Inc. Class A Common Stock is publicly traded.
What exchange does Bio-Rad Laboratories, Inc. Class A Common Stock trade on?
Bio-Rad Laboratories, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock?
The ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock is BIO on the New York Stock Exchange
What is the current price of Bio-Rad Laboratories, Inc. Class A Common Stock?
The current price of Bio-Rad Laboratories, Inc. Class A Common Stock is 247.06
When was Bio-Rad Laboratories, Inc. Class A Common Stock last traded?
The last trade of Bio-Rad Laboratories, Inc. Class A Common Stock was at 07/07/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.